drugset / Trial / NCT07580768

Sedation With Dexmedetomidine or Midazolam in Combination With Propofol for Removal of Double-J Ureteral Stent

NCT07580768

Completed 60 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to compare the efficacy of intravenous sedation using propofol alone or in combination with dexmedetomidine or midazolam for the removal of double J (D-J) ureteral stent.

Timeline

Start
2024-11-01
Primary completion
2025-10-01
Completion
2025-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous
Subject Midazolam Small molecule 0.05 mg/kg Intravenous
Comparator Propofol Small molecule 20 mg Intravenous

Indications

No indication recorded.